Why a Child Is Not a Small Adult

Part of Pediatric Trials: Why children need their own research.

About 4 minutes. Free, in your language, no account needed.

This is general education about clinical research — not medical advice, and not a way to join a study. Talk to your own doctor about your situation.

A reasonable question to ask is: if a medicine already works in adults, why not simply give children a smaller amount of it?

It is a fair question. The answer is that a child's body is not a scaled-down adult body.

Bodies at different stages handle medicines differently

A medicine has to be absorbed, distributed around the body, broken down, and removed. Every one of those steps depends on organs and systems that are still developing.

ICH E11, the international guideline on studying medicines in children, notes that knowing the pathways by which a medicine is cleared from the body — through the kidneys and through the liver's processing — and understanding how those processes change with age is often helpful in planning studies in children.

The plain version: the same amount of the same medicine can behave differently in a newborn, a toddler, a nine-year-old and an adult, and not in a way that a simple calculation from body weight reliably predicts.

Ingredients can affect children differently

This is the part that surprises people most, and it is worth stating with its example.

A medicine is not only its active ingredient. It also contains other substances that hold it together, preserve it, or make it possible to swallow. These are called excipients.

ICH E11 states that the toxicity of some excipients may vary across pediatric age groups, and between children and adults, and gives a specific example: benzyl alcohol is toxic in the preterm newborn.

So an ingredient that is entirely harmless in an adult may not be harmless in a very young child. That is not something a dose calculation can fix.

The medicine may not exist in a usable form

ICH E11 also describes the need for pediatric formulations that allow accurate dosing.

A tablet designed for an adult may not be swallowable by a four-year-old, may not be safely splittable into a small enough dose, and may taste bad enough that a child will not take it reliably. Liquids, suspensions and chewable forms may all be needed, at different strengths for different ages.

For injections, the guideline notes that appropriate concentrations need to be developed so that a small dose can be given accurately and safely.

Dosing is not just arithmetic

Doses for children are often calculated from body weight, up to a maximum adult dose. ICH E11 notes that dosing based on body surface area might in some ways be preferable, but that errors in measuring height in small children, and errors in calculating surface area, are common — so weight is generally used, with extra care taken for medicines where the margin between too little and too much is narrow.

That is a practical, honest description of a real trade-off, not a theoretical one.

What follows from all this

If a medicine is going to be used in children, the responsible thing is to study it in children. The alternative is not "no risk". The alternative is doctors having to estimate, for every child, with no data.

That is the argument for pediatric research. It sits alongside, and does not override, the rule from the last module: children should not be enrolled unless it is necessary for an important pediatric health need.

In short